🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate GMI-1271, a specific E-selectin antagonist, in mul...
Status
Completed
Location
Vejle Hospital
Start Date
2016-06
Trial ID
NCT02811822
Treatments Being Tested
Phase II trial to study the effectiveness of combining bortezomib with gemc...
Status
Completed
Location
Southwest Oncology Group
Start Date
2004-01
Trial ID
NCT00075751
Treatments Being Tested
Multiple myeloma (MM) is a cancer of the blood's plasma cells. The cancer i...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham - Main /ID# 261434
Start Date
2024-05-19
Trial ID
NCT06158841
Treatments Being Tested
The purpose of this study is to assess the efficacy, antitumor activity, sa...
Status
Recruiting
Location
University General Hospital of Patras
Start Date
2020-07-01
Trial ID
NCT04414475
Treatments Being Tested
This protocol corresponds to an open-label national phase II, multicenter, ...
Status
Completed
Location
Hospital Germans Trias i Pujol
Start Date
2011-07
Trial ID
NCT01376401
Treatments Being Tested
RATIONALE: Bortezomib may stop the growth of cancer cells by blocking some ...
Status
Completed
Location
Mayo Clinic
Start Date
2010-03
Trial ID
NCT01072773
Treatments Being Tested
This phase I trial studies the possible benefits and side effects of adding...
Status
Terminated
Location
Ohio State University Comprehensive Cancer Center
Start Date
2021-09-27
Trial ID
NCT04956302
Treatments Being Tested
RATIONALE: Bortezomib may stop the growth of cancer cells by blocking some ...
Status
Completed
Location
The University of Arizona Cancer Center
Start Date
2009-07-07
Trial ID
NCT00980395
Treatments Being Tested
Approximately 10,000 allogeneic hematopoietic stem cell transplants (HSCT) ...
Status
Terminated
Location
Northwestern University
Start Date
2010-10-07
Trial ID
NCT01163786
Treatments Being Tested
Bortezomib for treatment of disseminated MALT lymphoma or at relapse follow...
Status
Completed
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00373906
Treatments Being Tested